Global Antipsychotic Drugs Market 2017-2021

抗精神病薬の世界市場2017-2021

◆タイトル:Global Antipsychotic Drugs Market 2017-2021
◆商品コード:IRTNTR12354
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年6月7日
◆ページ数:83
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、抗精神病薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、抗精神病薬の世界市場規模及び予測、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

・エグゼクティブサマリー
・抗精神病薬の世界市場:市場概観
・抗精神病薬の世界市場:業界の構造分析
・抗精神病薬の世界市場:疾患概要
・抗精神病薬の世界市場:市場規模及び予測
・抗精神病薬の世界市場:地域別分析
・抗精神病薬の世界市場:アジア市場規模
・抗精神病薬の世界市場:アメリカ市場規模
・抗精神病薬の世界市場:ヨーロッパ市場規模
・抗精神病薬の世界市場:成長要因
・抗精神病薬の世界市場:課題
・抗精神病薬の世界市場:市場動向
・抗精神病薬の世界市場:競争状況
・抗精神病薬の世界市場:主要企業(ベンダー)分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

About Antipsychotic Drugs
Antipsychotic drugs are also called as major tranquilizers or neuroleptics. These drugs are primarily used for the treatment of psychiatric disorders such as schizophrenia, hallucinations, delusions, bipolar disorder, and others. The antipsychotic drugs market is expected to grow due to the rising number of schizophrenic patients.

Technavio’s analysts forecast the global antipsychotic drugs market to grow at a CAGR of 1.84% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global antipsychotic drugs market for 2017-2021. To calculate the market size, the report considers sales from both branded and generic drugs.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Antipsychotic Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• AstraZeneca
• Eli Lilly
• GlaxoSmithKline
• Johnson & Johnson

[Other prominent vendors]
• Actavis Generics (a subsidiary of Teva Pharmaceutical Industries)
• Alkermes
• Bristol-Myers Squibb

[Market driver]
• Increasing expenditure on prescription drugs
• For a full, detailed list, view our report

[Market challenge]
• Lack of standard diagnostic methods
• For a full, detailed list, view our report

[Market trend]
• Rising public interest toward mental health
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Disease overview
• Psychosis
• Symptoms of psychiatric disorder
• Causes of psychiatric disorder
• Treatment of psychiatric disorder
• Medical use of antipsychotic drugs

PART 06: Key clinical trials
• Key clinical trials

PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 08: Market segmentation by disease type
• Market overview based on disease type
• Schizophrenia
• Bipolar disorder
• Unipolar depression
• Dementia
• Others

PART 09: Market segmentation based on MoA
• Market overview based on MoA
• First-generation antipsychotic drugs market
• Second-generation antipsychotic drugs market
• Third generation antipsychotic drugs market

PART 10: Geographical segmentation
• Market overview based on geography
• Antipsychotic drugs market in Americas
• Antipsychotic drugs market in EMEA
• Antipsychotic drugs market in APAC

PART 11: Decision framework

PART 12: Drivers and challenges
• Market drivers
• Market challenges

PART 13: Market trends
• Rising public interest toward mental health
• Increase in use of LAI antipsychotic drugs
• Antipsychotics with novel MoA

PART 14: Vendor landscape
• Competitive landscape

PART 15: Key vendor analysis
• AstraZeneca
• Eli Lilly
• GlaxoSmithKline
• Johnson & Johnson
• Other prominent vendors

PART 16: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Reduction in prescription revenue over the years for antipsychotic drugs due to entry of generics
Exhibit 02: Signs and symptoms of psychiatric disorder
Exhibit 03: Causes of psychiatric disorder
Exhibit 04: List of medical conditions in which antipsychotic drugs used for the treatment
Exhibit 05: Stages of key clinical trials in global antipsychotic drugs market 2016
Exhibit 06: Snapshot of pipeline trends in global antipsychotic drugs market
Exhibit 07: Global antipsychotic drugs market 2016-2021 ($ millions)
Exhibit 08: Global antipsychotic drugs market: Opportunity analysis
Exhibit 09: Five forces analysis
Exhibit 10: Segmentation of global antipsychotic drugs market by disease type
Exhibit 11: Market share of global antipsychotic drugs market by disease type 2016
Exhibit 12: Global antipsychotic drugs market segmentation based on MoA 2016
Exhibit 13: Global first-generation antipsychotic drugs market 2016-2021 ($ millions)
Exhibit 14: Global second-generation antipsychotic drugs market 2016-2021 ($ millions)
Exhibit 15: Global third-generation antipsychotic drugs market 2016-2021 ($ millions)
Exhibit 16: Segmentation of global antipsychotic drugs market by geography 2016 and 2021
Exhibit 17: Global antipsychotic drugs market revenue by geography 2016-2021 ($ millions)
Exhibit 18: Global antipsychotic drugs market share by geography 2016-2021
Exhibit 19: Market scenario in Americas
Exhibit 20: Antipsychotic drugs market in Americas 2016-2021 ($ millions)
Exhibit 21: Market scenario in EMEA
Exhibit 22: Antipsychotic drugs market in EMEA 2016-2021 ($ millions)
Exhibit 23: Market scenario in APAC
Exhibit 24: Antipsychotic drugs market in APAC 2016-2021 ($ millions)
Exhibit 25: Competitive structure analysis of global antipsychotic drugs market 2016
Exhibit 26: AstraZeneca: Strength assessment
Exhibit 27: AstraZeneca: Strategy assessment
Exhibit 28: AstraZeneca: Opportunity assessment
Exhibit 29: AstraZeneca: Year-over-year (YoY) and growth rate of SEROQUEL XR and SEROQUEL IR 2014-2015 ($ millions)
Exhibit 30: Eli Lilly: Key highlights
Exhibit 31: Eli Lilly: Strength assessment
Exhibit 32: Eli Lilly: Strategy assessment
Exhibit 33: Eli Lilly: Opportunity assessment
Exhibit 34: GlaxoSmithKline: Strength assessment
Exhibit 35: GlaxoSmithKline: Strategy assessment
Exhibit 36: GlaxoSmithKline: Opportunity assessment
Exhibit 37: Johnson & Johnson: Key highlights
Exhibit 38: Johnson & Johnson: Strength assessment
Exhibit 39: Johnson & Johnson: Strategy assessment
Exhibit 40: Johnson & Johnson: Opportunity assessment



【掲載企業】

AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Actavis Generics (a subsidiary of Teva Pharmaceutical Industries), Alkermes, and Bristol-Myers Squibb.

【資料のキーワード】

抗精神病薬

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[抗精神病薬の世界市場2017-2021]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆